Tag Archives: teva

No Comments

CBOE Mid-Day Update 4.21.15

Volatility as an asset class Teva (TEVA) is recently up $1.23 to $64.52 after proposing to acquire all of the outstanding shares of Mylan (MYL) in a transaction valued at $82.00 per Mylan share, with the consideration to be comprised of approximately 50% cash and 50% stock. April weekly call option implied volatility is at […]






No Comments

Blogging Options: CBOE Morning Update 4.21.15

Markets look to add to yesterdays gains and Q1 earnings reports continue to flood in.  Overseas markets mostly higher, traders watching events overseas as a Chinese-owned company defaulted overnight and EU and Greece rhetoric getting louder.  May Crude futures expire today.  TEVA, Mylan merger being heard again this morning, Mylan had made a bid for […]






No Comments

Next Week in Weeklys

The summer doldrums have taken over and there is very little in the way of news related to Weeklys. There’s one new name and one stock reporting earnings next week. New on the list is Teva Pharmaceutical Industries Limited (TEVA) which is mostly known as a generic pharmaceutical company. On the earnings front the only […]






No Comments

Weekly Weeklies for 6.5.14

Weekly options are moving on headline events this week.  Let’s look at  weekly options set to expire Friday, June 6th and Friday the 13th. GM’S internal investigation of the ignition switch recall delay is out today. The stock has been revving up into the event. GM Weeklys upside calls for this week are active at […]






No Comments

Blogging Options: CBOE Mid-day Update 3.31.14

Volatility as an asset class AT&T (T) is recently up 4c to $35.12 after the company’s board of directors authorized the repurchase of up to 300M shares, or about 6% of its common shares outstanding. The company also noted it has 125M shares left under its buyback authorization that was issued in March of last […]